Incidence of cytomegalovirus infection in seropositive kidney transplant recipients treated with everolimus: A randomized, open-label, multicenter phase 4 trial

Hannah Kaminski, Nassim Kamar, Olivier Thaunat, Nicolas Bouvier, Sophie Caillard, Isabelle Garrigue, Dany Anglicheau, Jean-Philippe Rérolle, Yannick Le Meur, Antoine Dürrbach, Thomas Bachelet, Hélène Savel, Roxane Coueron, Jonathan Visentin, Arnaud Del Bello, Isabelle Pellegrin, Julie Déchanet‐Merville, Pierre Merville, Rodolphe Thiébaut, Lionel CouziAmerican 2022 · DOI

BibTeX
@inproceedings{kaminski2022incidence,
  author = {Hannah Kaminski and Nassim Kamar and Olivier Thaunat and Nicolas Bouvier and Sophie Caillard and Isabelle Garrigue and Dany Anglicheau and Jean-Philippe Rérolle and Yannick Le Meur and Antoine Dürrbach and Thomas Bachelet and Hélène Savel and Roxane Coueron and Jonathan Visentin and Arnaud Del Bello and Isabelle Pellegrin and Julie Déchanet‐Merville and Pierre Merville and Rodolphe Thiébaut and Lionel Couzi},
  title = {{Incidence of cytomegalovirus infection in seropositive kidney transplant recipients treated with everolimus: A randomized, open-label, multicenter phase 4 trial}},
  booktitle = {American},
  year = {2022},
  doi = {10.1111/ajt.16946},
}

Loading related content...

Figure